Back

The impact of age of onset and duration of Type 2 diabetes on life expectancy and serious health outcomes

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (3) Diabetes and the Heart ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jetish Isufi

Sahlgrenska University Hospital, Gothenburg (Sweden)

4 More presentations in this session

Presentation thumbnail
Progressive disease substrate in obese type 2 diabetic patients with coronary artery disease despite achieving HbA1c <7.0%: sub-analysis from the OPTIMAL randomized study
Doctor A. Salib (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
GLP-1 receptor agonists and SGLT2-inhibitors in patients with diabetes and ischaemic heart disease in primary care
Doctor T. Andersson (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Use of cardioprotective glucose lowering therapy before and after myocardial infarction among patients with type-2 diabetes: a nationwide registry study
Ms B. Sharad (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Tirzepatide and the risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials
Doctor E. Mansouri (Tehran, IR) Mr L. Barbosa (Belo Horizonte, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiovascular risk reduction: should we target pre-diabetes?
thumbnail
Congress Presentation
Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting
thumbnail
Congress Presentation
Diabetes as a major comorbidity in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources